[February 18, 2013]

Research and Markets: Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2012 Gives a Clear Account of the Market

Research and Markets (http://www.researchandmarkets.com/research/2wqj9k/allergic) has announced the addition of Global Markets Direct's new report "Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Allergic Rhino-Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Allergic Rhino-Conjunctivitis. Allergic Rhino-Conjunctivitis - Pipeline Review, HalfYear is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Allergic Rhino-Conjunctivitis.

- A review of the Allergic Rhino-Conjunctivitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Allergic Rhino-Conjunctivitis pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

ALK-Abello A/S

Allergy Therapeutics plc

Stallergenes S.A.

Cytos Biotechnology AG

Allergopharma Joachim Ganzer KG

Laboratorios LETI S.L.

For more information visit http://www.researchandmarkets.com/research/2wqj9k/allergic

Source (News - Alert): Global Markets Direct

[ Back To Technology News's Homepage ]